Rescue and repair of stalled ribosome damaged by ribosome-specific ribotoxins

被核糖体特异性核毒素损坏的停滞核糖体的拯救和修复

基本信息

项目摘要

Project Summary/Abstract In biology, there are two fundamental conflicts: the conflicts between organisms and the conflicts between organisms and viruses. During the conflicts, a variety of offensive and defensive weaponry are employed by organisms and viruses. While the molecular mechanisms of the conflicts between organisms and viruses have been extensively studied, significantly less have been carried out with the conflicts between organisms. During the conflicts between organisms, protein toxins are frequently employed as the offensive weapons. Among them, ribotoxins constitutes one of the biggest groups. In fact, colicin E3 was the first ribotoxin to be characterized 50 years ago. It makes a single but precise cut of 16S rRNA in the decoding center of bacterial ribosome, resulting in stalled ribosome and eventual cell death. Over the last half of a century, it is unclear whether there exists a biological system that is able to reverse the ribosomal damage by colicin E3 to allow cell to survive. Employing approaches of bioinformatics, biochemistry, structural biology, and microbiology, we have uncovered a bacterial two-component system, RtcB and PrfH, as the antidote of colicin E3. Specifically, bacterial PrfH recognizes the damaged and stalled ribosome and performs ribosomal rescue. This is followed by RtcB repairing the damaged 30S ribosomal subunit. The sequential events described above are supported by abundant preliminary data from both our in vitro and in vivo studies. In this application, we plan to significantly expand our preliminary studies to systematically characterize the rescue and repair of bacterial ribosome with specific damage in the decoding center with the following three main aims: 1) We will provide insight into bacterial PrfH recognizing and rescuing the damaged and stalled 70S ribosome in vitro; 2) We will biochemically and structurally characterize bacterial RtcB in vitro, with the emphasis of PrfH-coupled RtcB repairing the damaged 30S ribosomal subunit; and 3) We will elucidate in vivo biological functions of RtcB-PrfH using an in vivo attenuated RNA damage system we have developed.
项目摘要/摘要 在生物学中,有两个根本的冲突:有机体之间的冲突和生物之间的冲突 在有机体和病毒之间。在冲突期间,各种攻防武器装备 被有机体和病毒利用的。而生物体之间冲突的分子机制 人们对病毒进行了广泛的研究,但在冲突中进行的研究明显较少 在有机体之间。在生物体之间的冲突中,蛋白质毒素经常被用作 攻击性武器。其中,核毒素构成了最大的群体之一。事实上,粘菌素E3是 这是50年前发现的第一种核毒素。它对16S rRNA进行了一次但精确的切割 细菌核糖体的解码中心,导致核糖体停滞并最终导致细胞死亡。在过去的几年里 半个世纪以来,尚不清楚是否存在一种能够逆转核糖体的生物系统 粘菌素E3的破坏,使细胞得以存活。利用生物信息学、生物化学、 结构生物学和微生物学,我们已经发现了一个细菌双组分系统,RtcB和PrfH, 作为粘菌素E3的解毒剂。具体来说,细菌PrfH识别受损和停滞的核糖体,并 执行核糖体抢救。其次是RtcB修复受损的30S核糖体亚基。这个 上述顺序事件得到了来自我们的体外和体内的大量初步数据的支持 活体研究。在这项申请中,我们计划显著扩展我们的初步研究,以系统地 在解码中心表征具有特异性损伤的细菌核糖体的拯救和修复 以下三个主要目标:1)我们将深入了解细菌性PrfH识别和拯救 70s核糖体的体外损伤和停滞;2)我们将对细菌进行生化和结构表征 RtcB在体外,重点是PrfH偶联的RtcB修复受损的30S核糖体亚基; 我们将使用体内减弱的RNA损伤系统来阐明RtcB-PrfH的体内生物学功能 我们已经开发了。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Raven H Huang其他文献

Raven H Huang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Raven H Huang', 18)}}的其他基金

Rescue and repair of stalled ribosome damaged by ribosome-specific ribotoxins
被核糖体特异性核毒素损坏的停滞核糖体的拯救和修复
  • 批准号:
    10799097
  • 财政年份:
    2022
  • 资助金额:
    $ 30.37万
  • 项目类别:
Rescue and repair of stalled ribosome damaged by ribosome-specific ribotoxins
被核糖体特异性核毒素损坏的停滞核糖体的拯救和修复
  • 批准号:
    10467347
  • 财政年份:
    2022
  • 资助金额:
    $ 30.37万
  • 项目类别:
Generation and application of second messenger molecules by SMODS and SAVED
SMODS和SAVED第二信使分子的生成和应用
  • 批准号:
    9916469
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Generation and application of second messenger molecules by SMODS and SAVED
SMODS和SAVED第二信使分子的生成和应用
  • 批准号:
    10078261
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Genome-wide profiling of RNA damage and repair in vivo
体内 RNA 损伤和修复的全基因组分析
  • 批准号:
    9751333
  • 财政年份:
    2016
  • 资助金额:
    $ 30.37万
  • 项目类别:
Genome-wide profiling of RNA damage and repair in vivo
体内 RNA 损伤和修复的全基因组分析
  • 批准号:
    9352862
  • 财政年份:
    2016
  • 资助金额:
    $ 30.37万
  • 项目类别:
Genome-wide profiling of RNA damage and repair in vivo
体内 RNA 损伤和修复的全基因组分析
  • 批准号:
    9177493
  • 财政年份:
    2016
  • 资助金额:
    $ 30.37万
  • 项目类别:
Structure and Function of the Elongator Complex
伸长复合体的结构和功能
  • 批准号:
    9325029
  • 财政年份:
    2014
  • 资助金额:
    $ 30.37万
  • 项目类别:
Structure and Function of the Elongator Complex
伸长复合体的结构和功能
  • 批准号:
    9130210
  • 财政年份:
    2014
  • 资助金额:
    $ 30.37万
  • 项目类别:
Structure and Function of the Elongator Complex
伸长复合体的结构和功能
  • 批准号:
    8698011
  • 财政年份:
    2014
  • 资助金额:
    $ 30.37万
  • 项目类别:

相似海外基金

Novel oxime antidotes for an organophosphate insecticide requiring bioactivation
用于需要生物活化的有机磷杀虫剂的新型肟解毒剂
  • 批准号:
    10629574
  • 财政年份:
    2023
  • 资助金额:
    $ 30.37万
  • 项目类别:
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 30.37万
  • 项目类别:
Dual cavity baskets as nano antidotes for overdose with fentanyl and its derivatives
双腔篮作为芬太尼及其衍生物过量服用的纳米解毒剂
  • 批准号:
    10369058
  • 财政年份:
    2021
  • 资助金额:
    $ 30.37万
  • 项目类别:
Antidotes against HCI-induced chronic lung injury
针对 HCI 引起的慢性肺损伤的解毒剂
  • 批准号:
    10015581
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Antidotes against HCI-induced chronic lung injury
针对 HCI 引起的慢性肺损伤的解毒剂
  • 批准号:
    10241958
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
  • 批准号:
    10282997
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Antidotes against HCI-induced chronic lung injury
针对 HCI 引起的慢性肺损伤的解毒剂
  • 批准号:
    10471329
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
  • 批准号:
    10296690
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Hemoglobin-based antidotes for the treatment of carbon monoxide poisoning
用于治疗一氧化碳中毒的血红蛋白解毒剂
  • 批准号:
    9908358
  • 财政年份:
    2020
  • 资助金额:
    $ 30.37万
  • 项目类别:
Antidotes for Acute Cannabinoid Intoxication
急性大麻素中毒的解毒剂
  • 批准号:
    10460623
  • 财政年份:
    2018
  • 资助金额:
    $ 30.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了